These Are the 25 Best-Paying Jobs in America

Looking to score the big bucks? A new report finds that the best paying jobs in America are concentrated in health care, technology, and law.

Physicians have the highest median base salary, coming in at $187,876, according to the report from career website Glassdoor Inc. The second-highest salary went to pharmacy managers, a gig which requires both a pharmaceutical degree and management experience; patent attorney came in third. The report focused on U.S.-based employees and analyzed salaries that Glassdoor users entered on the site from February 2016 to January 2017. Only job titles with more than 100 salaries reported were considered for the study.

Of the 25 jobs best-paying jobs, 11 are in the tech industry, many in engineering. Silicon Valley is known for paying particularly well, with some first-year engineers in the area landing offers above $200,000, considering their salary together with cash and stock bonuses, according to a separate report. That may not be quite as lucrative as it sounds: The median monthly rent for a one-bedroom apartment in the Bay Area exceeds $3,000 a month.

Health-care jobs are also getting more lucrative: Last year, Glassdoor’s list included three jobs in the field; this year’s has six. Nurse practitioner comes in at 14th place, with a median annual salary of $104,144 and physician assistant landed seventh, at $112,529.

At the bottom of this list were two jobs known to pay well: nuclear engineer and attorney.

While working on nukes might seem exciting, Glassdoor’s website found only 155 job openings in this space, compared to more than 13,500 available roles for physician assistants. The median annual earnings of a nuclear engineer, $94,852, are about half those of a doctor.

Consider the life of a chef on the road. Even when they’re not doing “research” for an upcoming project—trips that are essentially designed for overeating and drinking—they’re still likely seeking the best of what got them into the industry in the first place: damn good food.

The proliferation of low-cost airlines flying out of the U.S. means that it’s now possible to hop to Europe for as low as half the price charged by major carriers, the New York Times writes. But there’s always a trade-off — and it pays to comparison-shop, according to the publication.

Featured Contributors

Chasing snake oil and fad gurus is harmless until your journey of personal discovery becomes a platform for prescribing therapies to complete strangers. Any reasonably diligent venture capital partner should be weighing the risks.

Shkreli — who famously insulted members of Congress earlier this year but refused to testify officially over his own decision to increase the price of a life-saving pill — is now hopping at the chance to defend generic drug manufacturer Mylan.
He may even have opened the door to testify before the House Committee on Oversight and Government Reform, where he previously cited his Fifth Amendment's right to avoid incriminating himself.
"Any chance i can come through this time and actually testify?" he tweeted Thursday in a post directed at the committee's Democrats.
All of this now paves an unlikely new friendship between Shkreli and Mylan CEO Heather Bresch.
Heather Bresch created about $15 billion in value for Mylan in the seven years since she stepped up as president of the company. A big part of that value add came from her talent for repackaging off-the-shelf drugs into bona fide blockbusters.

Donald Trump is talking about Hillary Clinton’s health, as are two doctors who havenever evaluated Clinton. They have apparently diagnosed her with all kinds of ailments using the long disproven Fox-Drudge equation.
This attention on Clinton has renewed some interest in the letter Donald Trump released last year from his personal physician.

Even as doctors enter a medical field with more paying patients under the Affordable Care Act and unprecedented numbers of job opportunities, 25 percent of “newly trained physicians” would still choose another field if they could, according to a new analysis.